tiprankstipranks
Advertisement
Advertisement

HK:2256 Stock Latest News

Abbisko and AstraZeneca Launch Joint Trial of Novel NSCLC Combination
Company AnnouncementsAbbisko and AstraZeneca Launch Joint Trial of Novel NSCLC Combination
10d ago
2256
Abbisko Showcases Promising Phase II FGFR2-Targeted Combo Data in Advanced Gastric Cancer
PremiumCompany Announcements
Abbisko Showcases Promising Phase II FGFR2-Targeted Combo Data in Advanced Gastric Cancer
16d ago
2256
Abbisko Deepens Lilly Partnership in Multitarget Drug R&D Deal Worth Up to US$1.9 Billion
PremiumCompany Announcements
Abbisko Deepens Lilly Partnership in Multitarget Drug R&D Deal Worth Up to US$1.9 Billion
18d ago
2256
Abbisko Showcases Advanced Modeling for Liver Cancer Drug ABSK-011 at European Meeting
PremiumCompany Announcements
Abbisko Showcases Advanced Modeling for Liver Cancer Drug ABSK-011 at European Meeting
1M ago
2256
Abbisko Shareholders Back All AGM Resolutions, Bolstering Capital and Governance Flexibility
PremiumCompany Announcements
Abbisko Shareholders Back All AGM Resolutions, Bolstering Capital and Governance Flexibility
2M ago
2256
Abbisko Cayman Raises HK$517 Million Through Share Placing to Fund Drug Development
PremiumCompany AnnouncementsAbbisko Cayman Raises HK$517 Million Through Share Placing to Fund Drug Development
2M ago
2256
Abbisko Moves to Modernise Governance With Digital-Ready Articles Update
Premium
Company Announcements
Abbisko Moves to Modernise Governance With Digital-Ready Articles Update
2M ago
2256
Abbisko Cayman Sets 2026 AGM to Approve Results, Board Changes and 20% Share Issue Mandate
Premium
Company Announcements
Abbisko Cayman Sets 2026 AGM to Approve Results, Board Changes and 20% Share Issue Mandate
2M ago
2256
Abbisko Showcases Broad Oncology Pipeline with Pan‑KRAS Data at 2026 AACR
PremiumCompany Announcements
Abbisko Showcases Broad Oncology Pipeline with Pan‑KRAS Data at 2026 AACR
3M ago
2256
Abbisko Cayman to Raise HK$517 Million via Discounted Share Placing for R&D Push
PremiumCompany Announcements
Abbisko Cayman to Raise HK$517 Million via Discounted Share Placing for R&D Push
3M ago
2256
Abbisko Grants 290,000 Share Options to Employees Under Post-IPO Scheme
PremiumCompany Announcements
Abbisko Grants 290,000 Share Options to Employees Under Post-IPO Scheme
3M ago
2256
Abbisko Wins EMA Orphan Drug Status for Liver Cancer Therapy Irpagratinib
PremiumCompany Announcements
Abbisko Wins EMA Orphan Drug Status for Liver Cancer Therapy Irpagratinib
3M ago
2256
Abbisko Wins FDA IND Clearance for Pediatric Achondroplasia Drug ABSK061
PremiumCompany AnnouncementsAbbisko Wins FDA IND Clearance for Pediatric Achondroplasia Drug ABSK061
3M ago
2256
Abbisko Wins FDA Orphan Drug Status for Achondroplasia Candidate ABSK061
Premium
Company Announcements
Abbisko Wins FDA Orphan Drug Status for Achondroplasia Candidate ABSK061
4M ago
2256
Abbisko Starts Phase II Trial of Irpagratinib Combo for Advanced Liver Cancer
Premium
Company Announcements
Abbisko Starts Phase II Trial of Irpagratinib Combo for Advanced Liver Cancer
4M ago
2256
Abbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061
PremiumCompany Announcements
Abbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061
4M ago
2256
Abbisko’s TGCT Drug Pimicotinib Clears Key Global Milestone With Lancet Phase 3 Publication
PremiumCompany Announcements
Abbisko’s TGCT Drug Pimicotinib Clears Key Global Milestone With Lancet Phase 3 Publication
4M ago
2256
Abbisko Advances KRAS G12D Cancer Program With First Patient Dosed in ABSK141 Trial
PremiumCompany Announcements
Abbisko Advances KRAS G12D Cancer Program With First Patient Dosed in ABSK141 Trial
4M ago
2256
Abbisko Chairman Boosts Stake, Signalling Confidence While Maintaining Public Float
PremiumCompany Announcements
Abbisko Chairman Boosts Stake, Signalling Confidence While Maintaining Public Float
4M ago
2256
Abbisko Wins First China Drug Approval, Reshuffles Secretaries as Merck Deepens Tie-Up
PremiumCompany AnnouncementsAbbisko Wins First China Drug Approval, Reshuffles Secretaries as Merck Deepens Tie-Up
4M ago
2256
Abbisko Cayman Sets March Board Meeting to Approve 2025 Results and Consider Dividend
Premium
Company Announcements
Abbisko Cayman Sets March Board Meeting to Approve 2025 Results and Consider Dividend
5M ago
2256
Abbisko Advances FGFR4 Inhibitor Irpagratinib With First U.S. Patient Dosed in Global HCC Trial
Premium
Company Announcements
Abbisko Advances FGFR4 Inhibitor Irpagratinib With First U.S. Patient Dosed in Global HCC Trial
5M ago
2256

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >